RVPH - Reviva to Participate in the H.C. Wainwright 25th Annual Global Investment Conference | Benzinga
CUPERTINO, Calif., Sept. 07, 2023 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) ("Reviva" or the "Company"), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), inflammatory and cardiometabolic diseases, today announced that Laxminarayan Bhat, Ph.D., Founder, President, and CEO of Reviva will both present and participate in a conference panel at the H.C. Wainwright 25th Annual Global Investment Conference, taking place September 11-13, 2023 virtually and in New York City, New York.
H.C. Wainwright 25th Annual Global Investment Conference
Format: Corporate update
Date/Time: Pre-recorded presentation available on-demand Monday, September 11 at 1:30 p.m. ET
Location: Virtual and Lotte New York Palace Hotel
Webcast Link: Click Here
Format: Conference panel: Emerging Therapies and Future Directions in Schizophrenia
Date/Time: Tuesday, September 12 at 3:30 p.m. ET
Location: Virtual and Lotte New York Palace Hotel
Management will also be participating in virtual one-on-one meetings throughout the event. To arrange a meeting with management, please contact your H.C. Wainwright sales ...